Skip to search.
 FTSE 100 Up 0.31%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
399.83 Down 3.14(0.78%) 20:55 - Nasdaq Real Time Price
Prev Close:402.97
Open:405.15
Bid:400.67 x 100
Ask:400.82 x 100
1y Target Est:466.64
Beta:1.45112
Earnings Date:2 Nov - 7 Nov (Est.)
Day's Range:396.59 - 405.99
52wk Range:329.09 - 592.59
Volume:495,531
Avg Vol (3m):827,048
Market Cap:42.91b
P/E (ttm):62.38
EPS (ttm):6.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.78%42.91b
AMGNDown 0.16%128.49b

Key Statistics

Forward P/E (1 yr):27.78
P/S (ttm):9.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :10.93
Quarterly EPS Est (Sep-16) :2.73
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback